HIV-1 non-nucleoside reverse transcriptase inhibitors

Bibliography

• SPENCE RA, KATI WM, ANDERSON KS, JOHNSON KA: of inhibition of HIV-1 reverse transcrip-tase by nonnucleoside inhibitors. Science (1995) 267:988–993.
   PubMed Web of Science ®Google Scholar
• HIRSCH MS: Current antiretrovirals - a review. Antivir. Ther. (1997) 2:19–40.
   Google Scholar
• BALZARINI J: Suppression of resistance to drugs targeted to human immunodeficiency virus reverse trascriptase by combination therapy. Biochem. Pharmacol. (1999) 58:1–27
   PubMed Web of Science ®Google Scholar
• PELEMANS H, ESNOUF RM, JONCKHEERE H et al.:Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. (1 9 9 8) 273(50:34324–34239.
   Google Scholar
• PEDERSEN OS, PEDERSEN EB: Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom. Antivir. Chem. Chemother. (1999) 10:285–314.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of the NNRTI area.
   Google Scholar
• PROUDFOOT JR: Non-nucleoside inhibitors of HIV-1reverse transcriptase. Exp. Opin. Ther. Patents (1998) 8 (8):971–982.
   Web of Science ®Google Scholar
• GROB PM, WU JC, COHEN KA et al: Nonnucleosideinhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. Aids Res. Hum. Retrovir. (1992) 8:145–152.
   PubMed Web of Science ®Google Scholar
• KLUNDER JM, HOERMANN MA, CYVIN CL et al.: Novelnonnucleoside inhibitors of Hill-1 reverse transcrip-tase. 7. 8-Arylethyldipyrido diazepinon es as potent broad-spectrum inhibitors of wild-type and mutant enzymes. J. Merl. Chem. (1998) 41:2960–2971.
   Google Scholar
• CYVIN CL, KLUNDER JM, HOERMANN MA et al: Novelnonnucleoside inhibitors of Hill-1 reverse transcrip-tase. 8. 8-Aryloxymethyl- and 8-arylthiomethyl dipyridodiazepinones. J. Merl. Chem. (1998) 41:2972–2984.
   PubMed Web of Science ®Google Scholar
• YOUNG SD, BRITCHER SF, TRAN LO et al: L-743,726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus Type 1 reverse transcriptase. Antimicrob. Agents Chemother. (1995) 39:2602–2605.
   PubMed Web of Science ®Google Scholar
• CORBETT JW, KO SS, RODGERS JD et al: Expanded-spectrum nonnucleoside reverse transcriptase inhibi-tors inhibit clinically relevant mutant variants of human immunodeficiency virus Type 1. Antimicrob. Agents Chemother. (1999) 43:2893–2897.
   PubMed Web of Science ®Google Scholar
• ••Development of efavirenz analogues with emphasis oncharacteristic mutants.
   Google Scholar
• PATEL M, KO SS, MCHUGH RJ, JR. et al: Synthesis andevaluation of analogs of efavirenz (Sustivai) as Hill-1 transcriptase inhibitors. Bioorg. Merl. Chem. Lett. (1999) 9:2805–2810.
   PubMed Web of Science ®Google Scholar
• PATEL M, MCHUGH JR RJ, CORDOVA BC et al: Synthesisand evaluation of benzoxazinones as Hill-1 reverse transcriptase inhibitors. Analogs of efavirenz (SustivaTh1). Bioorg. Merl. Chem. Lett. (1999) 9:3221–3224.
   PubMed Web of Science ®Google Scholar
• CORBETT JW, GEARHART LA, KO SS et al.: Novel2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadia zines as non-nucleoside reverse transcriptase inhibi-tors. Bioorg. Merl. Chem. Lett. (2000) 10:193–195.
   PubMed Web of Science ®Google Scholar
• AHGREN C, BACKRO K, BELL FW et al: The PEll series, anew class of potent nonucleoside inhibitors of human immunodeficiency virus Type 1 reverse transcriptase. Antimicrob. Agents Chemother. (1995) 39:1329–1335.
   PubMed Web of Science ®Google Scholar
• CANTRELL AS, ENGELHARDT P, HOGBERG M et al.: Phenethylthiazolylthiourea (PE11) compounds as a new class of Hill-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs. J. Merl. Chem. (1996) 39:4261–4274.
   Google Scholar
• HOGBERG M, SAHLBERG C, ENGELHARDT P et al: Urea-PEll compounds as anew class of Hill-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. J Merl. Chem. (1999) 42: 4150–4160.
   Google Scholar
• ••The most potent compounds to date on characteristicNNRTI induced mutants.
   Google Scholar
• HOGBERG M, SAHLBERG C, ENGELHARDT P et al: Cyclopropyl-Urea Compounds as Highly potent H1V-1 Reverse Transcriptase Inhibitors. Gordon Conference, Chemotherapy of AIDS. Ventura, California, USA (14–18 March 1999).
   Google Scholar
• MAO C, VIG R, VENKATACHALAM TK et al.: Structure-based design of N42-(1-piperidinylethyl)]-N'42-(5-bromopyridy1)]-thiourea and N42-(1-piperazinyl-ethyl)]-N42-(5-bromopyridy1)]-thiourea as potent nonnucleoside inhibitors of Hill-1 reverse transcrip-tase. Bioorg. Merl. Chem. Lett. (1998) 8:2213–2218.
   PubMed Web of Science ®Google Scholar
• MAO C, SUDBECK EA, VENKATACHALAM TK, UCKUN FM:Rational design of N42-(2,5-dimethoxyphenylethyl)]-N12-(5-bromopyridy1)]-thiourea (H1-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus. Bioorg. Merl. Chem. Lett. (1999) 9:1593–1598.
   PubMed Web of Science ®Google Scholar
• MAT A, ARTIGO M, SBARDELLA G et al.: Synthesis andanti-Hill-1 activity of thio analogues of dihydroalkoxy-benzyloxopyrimidines. J. Merl. Chem. (1995) 38:3258–3263.
   PubMed Web of Science ®Google Scholar
• MAT A, ARTICO M, SBARDELLA G et al.: Dihydro(alkylthio) (naphthylmethypoxopyrimidin es: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series. J. Merl. Chem. (1997) 40:1447–1454.
   PubMed Web of Science ®Google Scholar
• VIG R, MAO C, VENKATACHALAM TK et al.: 5 -Alkyl-2-[(methylthiomethyl)thio]-6 -(benzy1)-pyrimidin-4-(11-1)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series. Bioorg. Merl. Chem. Lett. (1998) 8:1461–1466.
   PubMed Web of Science ®Google Scholar
• MAT A, ARTICO M, SBARDELLA G et al.: 5-Alky1-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydrop yrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives. J. Med. Chem. (1999) 42:619–627.
   PubMed Web of Science ®Google Scholar
• WISHKA DG, GRABER DR, KOPTA LA et al.: (-)-6 -Chlor o -2-[(1 -fur o [2, 3-c]pyridin -5 -yl-ethyl)thio]-4-pyrimidinamine, PN1J-1 42 721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitor. J. Med. Chem. (1998) 41:1357–1360.
   PubMed Web of Science ®Google Scholar
• NUGENT RA, SCHLACHTER ST, MURPHY MJ et al.: Pyrimidine thioethers: a novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-r esistant HIV. J. Med. Chem. (1998) 41 : 3793–3803.
   PubMed Web of Science ®Google Scholar
• ••A good example of consistent development towards asecond generation inhibitor.
   Google Scholar
• BUCKHEIT JR RW, FLIAKAS-BOLTZ V, RUSSELL JD et al.: A non-nucleoside reverse transcriptase inhibitor with a unique sensitivity profile to drug-resistant virus isolates. Antivir. Chem. Chemother. (1996) 7:243–252.
   Web of Science ®Google Scholar